 Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Top-quality peptide freeze-dried powder Tirzepatide 20mg

Top-quality peptide freeze-dried powder Tirzepatide 20mg buy - large image1

Top-quality peptide freeze-dried powder Tirzepatide 20mg buy - image1

Top-quality peptide freeze-dried powder Tirzepatide 20mg buy - image2

Top-quality peptide freeze-dried powder Tirzepatide 20mg buy - image3

Top-quality peptide freeze-dried powder Tirzepatide 20mg buy - image4

Top-quality peptide freeze-dried powder Tirzepatide 20mg

Unit Price:

$64-79/MT EXW

Get Latest Price 

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Packaging:

10 vials/box

Price valid (until):

2027-09-01

Contact Supplier

 Chat Now

TONGQI FUTYRE LIMITED

Company Type:

Trader

Location:

Hongkong, China

Qualification:

Main Products:

Retatrutide

 Visit Store

Product Details
Seller Information

Description

Contact information

Name：Iris

Email：Xb20050416@gmail.com

WhatsApp：+852 6391 4517

Product Detail

Tirzepatide is a novel dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, primarily used to treat type 2 diabetes and obesity. By activating GIP and GLP-1 receptors, tirzepatide enhances insulin secretion, inhibits glucagon release, and delays gastric emptying. This dual mechanism not only effectively lowers blood glucose levels but also reduces appetite via the central nervous system, thereby facilitating weight management.

Name Tirzepatide

CAS NO. 2023788-19-2

Specifications 20mg

Purity 99%

Product Photos

Packing & Delivering

We utilize dedicated transport routes, ensuring fast, safe, and efficient delivery.

Basic Info

Product Name:
Peptide Tirzepatide TR20

Categories:
Bulk Drug Intermediates

Research

Class:
Dual agonist — GIPR, GLP-1R

Status:
FDA-approved (Mounjaro / Zepbound)

Mechanism:
Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

EC50 (Human GLP1R):
0.934 nM

EC50 (Human GIPR):
0.0224 nM

Source:
Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

Clinical Development:
NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503

FDA:
Mounjaro, Zepbound (approved 2022-05-13)

References

ChEMBL:
CHEMBL4297839

DrugBank:
DB15171

KEGG DRUG:
D11360

PubChem:
PubChem

Literature:
NEJM: Frias et al. (2021) — SURPASS-2; FDA: Mounjaro (NDA 215866)

Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Seller Information

Business Type:
Trader

Main Products:
Retatrutide

Location:
B27 SHING LEE COMM BLDG 8 WING KUT ST CENTRAL HONG KONG

Year of Establishment:
2026
Country Product Purchase Quantity Date Posted

Post an enquiry for this product

Top-quality peptide freeze-dried powder Tirzepatide 20mg

Product Details

Seller Information

Related Searches

More from this Seller

Name	Tirzepatide
CAS NO.	2023788-19-2
Specifications	20mg
Purity	99%